Early research (Phase 1)Not Yet RecruitingNCT06704347What this trial is testingSafety Study of XT-150 in Participants With ALSWho this might be right forAmyotrophic Lateral Sclerosis (ALS) Xalud Therapeutics, Inc. 8
Early research (Phase 1)Study completedNCT01405963What this trial is testingDouble-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic AsthmaWho this might be right forAsthma Amgen 31
Early research (Phase 1)Not Yet RecruitingNCT07824804What this trial is testingPhase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With ObesityWho this might be right forHealthy VolunteersObesity Shanghai Minwei Biotechnology Co., Ltd 48
Testing effectiveness (Phase 2)Looking for participantsNCT07805252What this trial is testingTrial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With CancerWho this might be right forAdvanced Solid Tumors Cancer Orion Corporation, Orion Pharma 195
Testing effectiveness (Phase 2)UnknownNCT05749549What this trial is testingPhase I/IIa Study of BR1733 in Subjects With Advanced CancersWho this might be right forAdvanced CancerFollicular LymphomaPeripheral T Cell Lymphoma+1 more Shanghai Blueray Biopharma Co., Ltd. 191
Early research (Phase 1)Study completedNCT02474134What this trial is testingComparison Study of PF530 and Betaferon in Healthy SubjectsWho this might be right forMultiple Sclerosis Pfenex, Inc 12
Early research (Phase 1)UnknownNCT04485884What this trial is testingEvaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male SubjectsWho this might be right forHealthy HK inno.N Corporation 42
Testing effectiveness (Phase 2)Study completedNCT03351738What this trial is testingEvaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart DiseaseWho this might be right forStable Coronary Heart Disease MedImmune LLC 133
Early research (Phase 1)Looking for participantsNCT06349473What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)Who this might be right forHealthy ParticipantsHemophilia AHemophilia B+1 more Equilibra Bioscience LLC 31
Testing effectiveness (Phase 2)Study completedNCT00184951What this trial is testingPharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV PatientsWho this might be right forHIV InfectionsHyperlipidemia Radboud University Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181What this trial is testingEvaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Ruijin Hospital 10
Early research (Phase 1)Ended earlyNCT00929370What this trial is testingA Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.Who this might be right forSchizophrenia GlaxoSmithKline 34
Testing effectiveness (Phase 2)Study completedNCT00291356What this trial is testingGSK189075, GW869682 Or Placebo In Type 2 Diabetic PatientsWho this might be right forDiabetes Mellitus, Type 2Non-Insulin-Dependent Diabetes Mellitus GlaxoSmithKline 45
Early research (Phase 1)Study completedNCT04593251What this trial is testingDose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic EsophagitisWho this might be right forEosinophilic EsophagitisCeliac Disease Calypso Biotech BV 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07386002What this trial is testingThe GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent GliomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype T-MAXIMUM Pharmaceutical Inc 40
Early research (Phase 1)Study completedNCT01488201What this trial is testingA Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe PsoriasisWho this might be right forPsoriasis Kyowa Kirin Co., Ltd. 48
Early research (Phase 1)Study completedNCT05654181What this trial is testingA First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult ParticipantsWho this might be right forHealthy Pfizer 20
Testing effectiveness (Phase 2)Ended earlyNCT01561430What this trial is testingStudy of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Eli Lilly and Company 70
Early research (Phase 1)Ended earlyNCT04045028What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma Genentech, Inc. 41
Early research (Phase 1)Ended earlyNCT00946972What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 33